- Home
- SNOA vs SILO Comparison
SNOA vs SILO Comparison
Compare SNOA & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNOA
- SILO
- Stock Information
- Founded
- SNOA 1999
- SILO 2010
- Country
- SNOA United States
- SILO United States
- Employees
- SNOA N/A
- SILO N/A
- Industry
- SNOA Biotechnology: Pharmaceutical Preparations
- SILO Apparel
- Sector
- SNOA Health Care
- SILO Consumer Discretionary
- Exchange
- SNOA Nasdaq
- SILO Nasdaq
- Market Cap
- SNOA 6.9M
- SILO 8.0M
- IPO Year
- SNOA 2007
- SILO N/A
- Fundamental
- Price
- SNOA $4.00
- SILO $0.54
- Analyst Decision
- SNOA
- SILO
- Analyst Count
- SNOA 0
- SILO 0
- Target Price
- SNOA N/A
- SILO N/A
- AVG Volume (30 Days)
- SNOA 76.8K
- SILO 840.4K
- Earning Date
- SNOA 11-07-2025
- SILO 11-12-2025
- Dividend Yield
- SNOA N/A
- SILO N/A
- EPS Growth
- SNOA N/A
- SILO N/A
- EPS
- SNOA N/A
- SILO N/A
- Revenue
- SNOA $14,912,000.00
- SILO $72,102.00
- Revenue This Year
- SNOA $23.00
- SILO $1.86
- Revenue Next Year
- SNOA $24.59
- SILO N/A
- P/E Ratio
- SNOA N/A
- SILO N/A
- Revenue Growth
- SNOA 17.43
- SILO N/A
- 52 Week Low
- SNOA $1.75
- SILO $0.40
- 52 Week High
- SNOA $6.92
- SILO $3.37
- Technical
- Relative Strength Index (RSI)
- SNOA 49.74
- SILO 38.98
- Support Level
- SNOA $3.57
- SILO $0.53
- Resistance Level
- SNOA $4.02
- SILO $0.62
- Average True Range (ATR)
- SNOA 0.23
- SILO 0.06
- MACD
- SNOA 0.00
- SILO -0.01
- Stochastic Oscillator
- SNOA 58.63
- SILO 51.62
About SNOA Sonoma Pharmaceuticals Inc.
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.
About SILO Silo Pharma Inc.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.